UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis

Nature medicine, 2019-08, Vol.25 (8), p.1290-1300

2019

Volltextzugriff (PDF)

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

PloS one, 2015-07, Vol.10 (7), p.e0132177-e0132177

2015

Volltextzugriff (PDF)

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study

European journal of neurology, 2024-08, Vol.31 (8), p.e16331-n/a

2024

Volltextzugriff (PDF)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury

Scientific reports, 2020-10, Vol.10 (1), p.18075-18075, Article 18075

2020

Volltextzugriff (PDF)

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis

PloS one, 2015-04, Vol.10 (4), p.e0122048-e0122048

2015

Volltextzugriff (PDF)

Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury

Clinical chemistry and laboratory medicine, 2019, Vol.57 (10), p.1565-1573

2019

Volltextzugriff (PDF)

A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury

Journal of neurotrauma, 2019-10, Vol.36 (20), p.2850-2862

2019

Volltextzugriff (PDF)

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2020-10, Vol.6 (4), p.2055217320964505-2055217320964505

2020

Volltextzugriff (PDF)

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Nature communications, 2019-07, Vol.10 (1), p.3081-13, Article 3081

2019

Volltextzugriff (PDF)

Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study

Critical care (London, England), 2021-03, Vol.25 (1), p.103-103, Article 103

2021

Volltextzugriff (PDF)

B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients

European journal of neurology, 2022-11, Vol.29 (11), p.3317-3328

2022

Volltextzugriff (PDF)

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis

Annals of neurology, 2024-06, Vol.95 (6), p.1112-1126

2024

Volltextzugriff (PDF)

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (17), p.1

2021

Volltextzugriff (PDF)

Variability in C-Type Lectin Receptors Regulates Neuropathic Pain-Like Behavior after Peripheral Nerve Injury

Molecular pain, 2014-12, Vol.10 (1), p.78-78

2014

Volltextzugriff (PDF)

Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury

The Journal of immunology (1950), 2021-07, Vol.207 (1), p.90-100

2021

Volltextzugriff (PDF)

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers

PloS one, 2013-05, Vol.8 (5), p.e63172-e63172

2013

Volltextzugriff (PDF)

Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate

Neurotherapeutics, 2020-07, Vol.17 (3), p.1142-1152

2020

Volltextzugriff (PDF)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

iScience, 2021-09, Vol.24 (9), p.103078-103078, Article 103078

2021

Volltextzugriff (PDF)

Morvan’s syndrome treated successfully with rituximab and lacosamide

BMJ case reports, 2019-02, Vol.12 (2), p.e226832

2019

Volltextzugriff (PDF)

Copy number variations across the blood–brain barrier in multiple sclerosis

Annals of clinical and translational neurology, 2022-07, Vol.9 (7), p.962-976

2022

Volltextzugriff (PDF)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

Neurology : neuroimmunology & neuroinflammation, 2016-02, Vol.3 (1), p.e191-e191

2016

Volltextzugriff (PDF)

iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion

Acta neurochirurgica, 2012-04, Vol.154 (4), p.689-697

2012

Volltextzugriff (PDF)

Unbiased expression mapping identifies a link between the complement and cholinergic systems in the rat central nervous system

The Journal of immunology (1950), 2014-02, Vol.192 (3), p.1138-1153

2014

Volltextzugriff (PDF)

Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response

Journal of neuroinflammation, 2015-10, Vol.12 (1), p.192-192, Article 192

2015

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury

Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis

Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury

A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study

B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients

HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis

Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology

Variability in C-Type Lectin Receptors Regulates Neuropathic Pain-Like Behavior after Peripheral Nerve Injury

Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers

Characterization of More Selective Central Nervous System Nrf2-Activating Novel Vinyl Sulfoximine Compounds Compared to Dimethyl Fumarate

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

Morvan’s syndrome treated successfully with rituximab and lacosamide

Copy number variations across the blood–brain barrier in multiple sclerosis

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination

iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion

Unbiased expression mapping identifies a link between the complement and cholinergic systems in the rat central nervous system

Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response

Suchergebnisse filtern